The DOI matches its Crossref record; 63 of the 73 references it cites were found in a registry or an index.
DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2
Open accessAbstract
DNA-damaging agents signal to p53 through as yet unidentified posttranscriptional mechanisms. Here we show that phosphorylation of human p53 at serine 15 occurs after DNA damage and that this leads to reduced interaction of p53 with its negative regulator, the oncoprotein MDM2, in vivo and in vitro. Furthermore, using purified DNA-dependent protein kinase (DNA-PK), we demonstrate that phosphorylation of p53 at serines 15 and 37 impairs the ability of MDM2 to inhibit p53-dependent transactivation. We present evidence that these effects are most likely due to a conformational change induced upon phosphorylation of p53. Our studies provide a plausible mechanism by which the induction of p53 can be modulated by DNA-PK (or other protein kinases with similar specificity) in response to DNA damage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Doxorubicin treatment of early passage tumor cell lines revealed that five of five early generation mTerc Ink4a / Arf -/ -tumors maintained intact p53 response evidenced by p53 Ser-18 phosphorylation (37, 38) and associated induction of p21 CIP1 .”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [37]
In the citing paper
“Induction of double strand breaks in DNA by ionizing radiation or genotoxic chemotherapy leads to the rapid stabilization of p53 through phosphorylation of its N terminus (Shieh et al. 1997; Siliciano et al. 1997”
From p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis (1999) · cites this paper as Shieh et al. 1997
In the citing paper
“ATM also activates Chk2, which in turn phosphorylates p53 on serine 20 and inhibits MDM2 binding (Shieh et al, 1997;Banin et al, 1998;Chehab et al, 2000;Shieh et al, 2000).”
From ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage (2005) · cites this paper as Shieh et al, 1997
In the citing paper
“ATM also activates Chk2, which in turn phosphorylates p53 on S20, which is a part of the MDM2-binding site (Shieh et al, 1997(Shieh et al, , 2000;;Banin et al, 1998;Chehab et al, 2000).”
From ATM activates p53 by regulating MDM2 oligomerization and E3 processivity (2009) · cites this paper as Shieh et al, 1997
In the citing paper
“Several landmark studies showed that DNA double strand breaks induce phosphorylation of p53 S15 by DNA-PK and ATM (Mayo et al, 1997;Shieh et al, 1997;Banin et al, 1998;Prives and Hall, 1999).”
From ATM activates p53 by regulating MDM2 oligomerization and E3 processivity (2009) · cites this paper as Shieh et al, 1997
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
p53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346
Self-citationStructure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206
The p53-mdm-2 autoregulatory feedback loop.
Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., & Vogelstein, B. (1993) · Nature · doi:10.1038/362857a0 · Cited by 1,474
Research works printed but not linked: 3
- Hawley, 1996, Stange bedfellows in even stranger places, Genes Dev., 10, 1383
- Meek, 1994, Posttranslational modification of p53, Semin. Cancer Biol., 5, 203
- Nelson, 1994, DNA strand breaks, Mol. Cell. Biol., 14, 1815
Cited by
Sorted by citations
Items 301–400 of 1,005
Role of p53 in Neurodegenerative Diseases
Chang, J. R., Ghafouri, M., Mukerjee, R., Bagashev, A., Chabrashvili, T., & Sawaya, B. E. (2011) · Neurodegenerative Diseases · doi:10.1159/000329999 · Cited by 149
JMJD6 Promotes Colon Carcinogenesis through Negative Regulation of p53 by Hydroxylation
Wang, F., He, L., Huangyang, P., Liang, J., Si, W., Yan, R., Han, X., Liu, S., Gui, B., Li, W., et al. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001819 · Cited by 144
Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine
Fiorini, C., Cordani, M., Padroni, C., Blandino, G., Agostino, S. D., & Donadelli, M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.10.003 · Cited by 151
The loss of mdm2 induces p53 mediated apoptosis
de Rozìeres, S., Maya, R. B.-Y., Oren, M., & Lozano, G. (2000) · Oncogene · doi:10.1038/sj.onc.1203468 · Cited by 146
Wang, W., Takimoto, R., Rastinejad, F., & El‐Deiry, W. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.6.2171-2181.2003 · Cited by 144
The cell death machinery governed by the p53 tumor suppressor in response to DNA damage
Yoshida, K., & Miki, Y. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01488.x · Cited by 151
Alarcon, R. M., Koumenis, C., Geyer, R. K., Maki, C. G., & Giaccia, A. J. (1999) · PubMed · Cited by 143
Pise-Masison, C. A., Mahieux, R., Jiang, H., Ashcroft, M. A., Radonovich, M. F., Duvall, J. F., Guillerm, C., & Brady, J. N. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.10.3377-3386.2000 · Cited by 148
STAT1 and pathogens, not a friendly relationship
Najjar, I., & Fagard, R. (2010) · Biochimie · doi:10.1016/j.biochi.2010.02.009 · Cited by 147
Arsenite induces p53 accumulation through an ATM-dependent pathway in human fibroblasts.
Yih, L., & Lee, T. (2000) · PubMed · Cited by 142
Protein kinase CK1 is a p53‐threonine 18 kinase which requires prior phosphorylation of serine 15
Dumaz, N., Milne, D., & Meek, D. W. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01647-6 · Cited by 145
Kaelin, W. G. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.7.594 · Cited by 143
Cell Type- and Promoter-specific Roles of Ser18 Phosphorylation in Regulating p53 Responses
Chao, C., Hergenhahn, M., Kaeser, M. D., Wu, Z., Saito, S., Iggo, R., Hollstein, M., Appella, E., & Xu, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306938200 · Cited by 141
Dutta, S., Warshall, C., Bandyopadhyay, C., Dutta, D., & Chandran, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097580 · Cited by 142
Puca, R., Nardinocchi, L., Givol, D., & D’Orazi, G. (2010) · Oncogene · doi:10.1038/onc.2010.183 · Cited by 141
DNA damage induces two distinct modes of cell death in ovarian carcinomas
Vakifahmetoglu, H., Olsson, M., Tamm, C., Heidari, N., Orrenius, S., & Zhivotovsky, B. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402286 · Cited by 140
The role of the ubiquitin/proteasome system in cellular responses to radiation
McBride, W. H., Iwamoto, K. S., Syljuåsen, R. G., Pervan, M., & Pajonk, F. (2003) · Oncogene · doi:10.1038/sj.onc.1206676 · Cited by 145
Understanding p53 functions through p53 antibodies
Sabapathy, K., & Lane, D. P. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz010 · Cited by 139
Chêne, P., Fuchs, J. P., Bohn, J. A., Garcı́a-Echeverrı́a, C., Furet, P., & Fabbro, D. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3738 · Cited by 139
An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2
Evans, S. C., Viswanathan, M., Grier, J. D., Narayana, M., El‐Naggar, A. K., & Lozano, G. (2001) · Oncogene · doi:10.1038/sj.onc.1204533 · Cited by 138
Turenne, G. A., & Price, B. D. (2001) · BMC Cell Biology · doi:10.1186/1471-2121-2-12 · Cited by 139
Katiyar, S. K., Roy, A. M., & Baliga, M. S. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.207.4.2 · Cited by 139
Roles of COP9 signalosome in cancer
Lee, M., Zhao, R., Phan, L. M., & Yeung, S. J. (2011) · Cell Cycle · doi:10.4161/cc.10.18.17320 · Cited by 137
Cuddihy, A. R., Li, S., Tam, N. W. N., Wong, A. H., Taya, Y., Abraham, N., Bell, J. C., & Koromilas, A. E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2475 · Cited by 137
Self-citationWu, W. D., Chen, Z.-J., Zhang, K.-S., Yang, X.-L., Wu, Y.-M., Chen, X.-H., Huang, H.-B., Liu, H.-L., Cai, S.-H., Du, J., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.398 · Cited by 136
Human papillomavirus E6 and E7: What remains?
Vats, A., Trejo-Cerro, Ó., Thomas, M., & Banks, L. (2021) · Tumour Virus Research · doi:10.1016/j.tvr.2021.200213 · Cited by 141
The p53 protein family and radiation sensitivity: Yes or no?
Cuddihy, A. R., & Bristow, R. G. (2004) · Cancer and Metastasis Reviews · doi:10.1023/b:canc.0000031764.81141.e4 · Cited by 137
Shin, Y. C., Nakamura, H., Liang, X., Feng, P., Chang, H., Kowalik, T. F., & Jung, J. U. (2006) · Journal of Virology · doi:10.1128/jvi.80.5.2257-2266.2006 · Cited by 137
Lavin, M. F. (1999) · International Journal of Radiation Biology · doi:10.1080/095530099139359 · Cited by 137
Stabilization of p53 Is Involved in Quercetin-Induced Cell Cycle Arrest and Apoptosis in HepG2 Cells
TANIGAWA, S., FUJII, M., & HOU, D.-X. (2008) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.70680 · Cited by 135
Role of p53, PUMA, and Bax in wogonin-induced apoptosis in human cancer cells
Lee, D., Kim, C., Zhang, L., & Lee, Y. J. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.02.023 · Cited by 134
Karunakaran, S., Saeed, U., Mishra, M., Valli, R. K., Joshi, S. D., Meka, D. P., Seth, P., & Ravindranath, V. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4511-08.2008 · Cited by 134
Latonen, L., Taya, Y., & Laiho, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204883 · Cited by 134
Self-citationDyrk1A phosphorylates p53 and inhibits proliferation of embryonic neuronal cells
Park, J., Oh, Y., Yoo, L., Jung, M.-S., Song, W.-J., Lee, S.-H., Seo, H., & Chung, K. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.147520 · Cited by 134
Protein degradation and the stress response
Flick, K. M., & Kaiser, P. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.01.019 · Cited by 135
Induction of SOX4 by DNA damage is critical for p53 stabilization and function
Pan, X., Zhao, J., Zhang, W.-N., Li, H., Mu, R., Zhou, T., Zhang, H., Gong, W.-L., Yu, M., Man, J.-H., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810147106 · Cited by 135
The α-helical FXXΦΦ motif in p53: TAF interaction and discrimination by MDM2
Uesugi, M., & Verdine, G. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14801 · Cited by 133
O’Keefe, K. J., Li, H., & Zhang, Y. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.18.6396-6405.2003 · Cited by 133
Pise-Masison, C. A., Radonovich, M. F., Sakaguchi, K., Appella, E., & Brady, J. N. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6348-6355.1998 · Cited by 134
Stabler, S. M., Ostrowski, L. L., Janicki, S. M., & Monteiro, M. J. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.145.6.1277 · Cited by 132
HPV 5 and 8 E6 Abrogate ATR Activity Resulting in Increased Persistence of UVB Induced DNA Damage
Wallace, N. A., Robinson, K. L., Howie, H. L., & Galloway, D. A. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002807 · Cited by 134
Nucleotide Biosynthetic Enzyme GMP Synthase Is a TRIM21-Controlled Relay of p53 Stabilization
Reddy, B. A., van der Knaap, J. A., Bot, A. G. M., Mohd-Sarip, A., Dekkers, D. H. W., Timmermans, M. A. M., Martens, J. W. M., Demmers, J., & Verrijzer, C. P. (2014) · Molecular Cell · doi:10.1016/j.molcel.2013.12.017 · Cited by 133
Kawauchi, J., Zhang, C., Nobori, K., Hashimoto, Y., Adachi, M. T., Noda, A., Sunamori, M., & Kitajima, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202974200 · Cited by 131
Covalent and noncovalent modifiers of the p53 protein
Jayaraman, L., & Prives, C. L. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050271 · Cited by 132
Self-citationThe ataxia-telangiectasia related protein ATR mediates DNA-dependent phosphorylation of p53
Lakin, N. D., Hann, B. C., & Jackson, S. P. (1999) · Oncogene · doi:10.1038/sj.onc.1202973 · Cited by 135
Nakagawa, K., Taya, Y., Tamai, K., & Yamaizumi, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2828 · Cited by 134
Self-citationSuzuki, K., Kodama, S., & Watanabe, M. (2001) · PubMed · Cited by 130
Kao, C.-F., Chen, S.-Y., Chen, J., & Lee, Y. W. (2004) · Oncogene · doi:10.1038/sj.onc.1207368 · Cited by 129
p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells
Hideshima, T., Podar, K., Chauhan, D., Ishitsuka, K., Mitsiades, C. S., Tai, Y., Hamasaki, M., Raje, N. S., Hideshima, H., Schreiner, G. F., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1208118 · Cited by 129
Ghouzzi, V. E., Bianchi, F. T., Molineris, I., Mounce, B. C., Berto, G. E., Rak, M., Lebon, S., Aubry, L., Tocco, C., Gai, M., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.266 · Cited by 130
Chouinard, N., Valerie, K. C., Rouabhia, M., & Huot, J. (2002) · Biochemical Journal · doi:10.1042/bj20020072 · Cited by 128
Human p53 Is Phosphorylated on Serines 6 and 9 in Response to DNA Damage-inducing Agents
Higashimoto, Y., Saito, S., Tong, X., Hong, A. L., Sakaguchi, K., Appella, E., & Anderson, C. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002674200 · Cited by 128
A High-Frequency Regulatory Polymorphism in the p53 Pathway Accelerates Tumor Development
Post, S. M., Quintás-Cardama, A., Pant, V., Iwakuma, T., Hamir, A., Jackson, J. G., Maccio, D. R., Bond, G. L., Johnson, D. G., Levine, A. J., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.07.010 · Cited by 127
New insights into p53 activation
Brooks, C. L., & Gu, W. (2010) · Cell Research · doi:10.1038/cr.2010.53 · Cited by 102
Granata, C., Jamnick, N. A., & Bishop, D. J. (2018) · Sports Medicine · doi:10.1007/s40279-018-0894-4 · Cited by 135
Keller, D. M., & Lu, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209820200 · Cited by 127
HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53Preprint
Sasaki, T., Gan, E. C., Wakeham, A. C., Kornbluth, S. A., Mak, T. W., & Okada, H. (2007) · Genes & Development · doi:10.1101/gad.1534107 · Cited by 130
Thymidylate synthase as a translational regulator of cellular gene expression
Liu, J., Schmitz, J. C., Lin, X., Tai, N., Wu, Y., Farrell, M., Bailly, M., Chen, T.-M., & Chu, E. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00080-7 · Cited by 126
Oligomerization Is Required for p53 to be Efficiently Ubiquitinated by MDM2
Maki, C. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16531 · Cited by 125
Defective apoptosis and B-cell lymphomas in mice with p53 point mutation at Ser 23
MacPherson, D., Kim, J., Kim, T., Rhee, B. K., van Oostrom, C. T., DiTullio, R. A., Venere, M., Halazonetis, T. D., Bronson, R., de Vries, A., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600363 · Cited by 124
Metformin and neoplasia: Implications and indications
Aljada, A., & Mousa, S. A. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.09.004 · Cited by 128
Hein, J., Boichuk, S., Wu, J., Cheng, Y., Freire, R., Jat, P., Roberts, T. M., & Gjoerup, O. V. (2008) · Journal of Virology · doi:10.1128/jvi.01515-08 · Cited by 125
Rao, F., Cha, J., Xu, J., Xu, R., Vandiver, M. S., Tyagi, R., Tokhunts, R. A., Koldobskiy, M. A., Fu, C., Barrow, R. K., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.02.020 · Cited by 126
Interaction of Akt-phosphorylated SRPK2 with 14-3-3 Mediates Cell Cycle and Cell Death in Neurons
Jang, S., Liu, X., Fu, H., Rees, H. D., Yepes, M., Levey, A. I., & Ye, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.026237 · Cited by 127
Biological determinants of radioresistance and their remediation in pancreatic cancer
Seshacharyulu, P., Baine, M. J., Souchek, J. J., Menning, M., Kaur, S., Yan, Y., Ouellette, M. M., Jain, M., Lin, C. H., & Batra, S. K. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.02.003 · Cited by 127
(1999) · PubMed · Cited by 123
Molecular targets of apigenin in colorectal cancer cells: Involvement of p21, NAG-1 and p53
Zhong, Y., Krisanapun, C., Lee, S., Nualsanit, T., Sams, C. E., Peungvicha, P., & Baek, S. J. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.07.007 · Cited by 123
Ariumi, Y., Kaida, A., Lin, J.-Y., Hirota, M., Masui, O., Yamaoka, S., Taya, Y., & Shimotohno, K. (2000) · Oncogene · doi:10.1038/sj.onc.1203450 · Cited by 123
Self-citationKishi, H., Nakagawa, K., Matsumoto, M., Suga, M., Ando, M., Taya, Y., & Yamaizumi, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105134200 · Cited by 129
Self-citationActivated oncogenes promote and cooperate with chromosomal instability for neoplastic transformationPreprint
Woo, R. A., & Poon, R. Y. C. (2004) · Genes & Development · doi:10.1101/gad.1165204 · Cited by 129
Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3
LeBron, C., Chen, L., Gilkes, D. M., & Chen, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601032 · Cited by 122
DNA damage and cell cycle checkpoints in hyperoxic lung injury: braking to facilitate repair
O’Reilly, M. A. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.2.l291 · Cited by 122
Suppression of the poly(ADP-ribose) polymerase activity by DNA-dependent protein kinase in vitro
Ariumi, Y., Masutani, M., Copeland, T. D., Mimori, T., Sügimura, T., Shimotohno, K., Ueda, K., Hatanaka, M., & Noda, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202823 · Cited by 122
Keeping an old friend under control: regulation of p53 stability
Kubbutat, M. H. G., & Vousden, K. H. (1998) · Molecular Medicine Today · doi:10.1016/s1357-4310(98)01260-x · Cited by 122
Increased apoptosis induction by 121F mutant p53
Saller, E., Tom, E., Brunori, M., Otter, M., Estreicher, A., Mack, D. H., & Iggo, R. D. (1999) · The EMBO Journal · doi:10.1093/emboj/18.16.4424 · Cited by 124
Nagel, D. J., Aizawa, T., Jeon, K., Liu, W., Mohan, A. M., Wei, H., Miano, J. M., Florio, V. A., Gao, P., Korshunov, V. A., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000215576.27615.fd · Cited by 127
Karimian, A., Majidinia, M., Baghi, H. B., & Yousefi, B. (2017) · DNA repair · doi:10.1016/j.dnarep.2017.01.003 · Cited by 125
Protective Effects of Catalase Overexpression on UVB-induced Apoptosis in Normal Human Keratinocytes
Rezvani, H. R., Mazurier, F., Cario, M., Pain, C., Ged, C., Taı̈eb, A., & de Verneuil, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600536200 · Cited by 120
Turenne, G. A., Paul, P., Laflair, L., & Price, B. D. (2001) · Oncogene · doi:10.1038/sj.onc.1204665 · Cited by 120
The antiangiogenic agent TNP-470 requires p53 and p21 CIP/WAF for endothelial cell growth arrest
Yeh, J.-R. J., Mohan, R., & Crews, C. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12782 · Cited by 120
Woo, R. A., Jack, M. T., Xu, Y., Burma, S., Chen, D. J., & Lee, P. W. K. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf307 · Cited by 122
Histone methylation modifiers in cellular signaling pathways
Alam, H., Gu, B., & Lee, M. G. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2023-y · Cited by 124
The ribosomal protein S26 regulates p53 activity in response to DNA damage
Cui, D., Li, L., Lou, H., Sun, H., Ngai, S. H. O., Shao, G., & Tang, J. (2013) · Oncogene · doi:10.1038/onc.2013.170 · Cited by 121
Mallette, F. A., & Richard, S. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.033 · Cited by 125
Fox, D. K., Ebert, S. M., Bongers, K. S., Dyle, M. C., Bullard, S. A., Dierdorff, J. M., Kunkel, S. D., & Adams, C. M. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00010.2014 · Cited by 125
Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F‐1 after DNA damage
Inoue, Y., Kitagawa, M., & Taya, Y. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601652 · Cited by 119
Self-citationThe multiple checkpoint functions of CHK1 and CHK2 in maintenance of genome stability.
Chen, Y., & Poon, R. Y. C. (2008) · PubMed · doi:10.2741/3060 · Cited by 119
Tsoporis, J. N., Izhar, S., Leong-Poi, H., Desjardins, J.-F., Huttunen, H. J., & Parker, T. G. (2010) · Circulation Research · doi:10.1161/circresaha.109.195834 · Cited by 118
Phosphorylation on Thr-55 by TAF1 Mediates Degradation of p53
Li, H.-H., Li, A. G., Sheppard, H. M., & Liu, X. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00123-6 · Cited by 118
Body language: the function of PML nuclear bodies in apoptosis regulation
Hofmann, T. G., & Will, H. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401313 · Cited by 121
A Small-Molecule Inhibitor of MDMX Activates p53 and Induces Apoptosis
Wang, H., Ma, X., Ren, S., Buolamwini, J. K., & Yan, C. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0581 · Cited by 117
Regulation of p53 stability and function by the deubiquitinating enzyme USP42
Hock, A. K., Vigneron, A. M., Carter, S., Ludwig, R. L., & Vousden, K. H. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.419 · Cited by 117
Kamijo, T., van de Kamp, E. H., Chong, M. J., Zindy, F., Diehl, J. A., Sherr, C. J., & McKinnon, P. J. (1999) · PubMed · Cited by 117
UHRF1 depletion causes a G2/M arrest, activation of DNA damage response and apoptosis
Tien, A. L., SenBanerjee, S., Kulkarni, A., Mudbhary, R., Goudreau, B. J., Ganesan, S., Sadler, K. C., & Ukomadu, C. (2011) · Biochemical Journal · doi:10.1042/bj20100840 · Cited by 117
p53: Twenty five years understanding the mechanism of genome protection
Gómez-Lázaro, M., Fernández-Gómez, F.-J., & Jordán, J. (2004) · Journal of Physiology and Biochemistry · doi:10.1007/bf03167075 · Cited by 119
Anticancer effects of oleuropein
Shamshoum, H., Vlavcheski, F., & Tsiani, E. (2017) · BioFactors · doi:10.1002/biof.1366 · Cited by 119
P53 Dysfunction in Neurodegenerative Diseases - The Cause or Effect of Pathological Changes?
Szybińska, A., & Leśniak, W. (2017) · Aging and Disease · doi:10.14336/ad.2016.1120 · Cited by 118
de Aguilar, J. G., Gordon, J. W., René, F., de Tapia, M., Lutz‐Bucher, B., Gaiddon, C., & Loeffler, J. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0295 · Cited by 115
Recruitment of ATM Protein to Double Strand DNA Irradiated with Ionizing Radiation
Suzuki, K., Kodama, S., & Watanabe, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25571 · Cited by 115
p53—A Natural Cancer Killer: Structural Insights and Therapeutic Concepts
Römer, L., Klein, C., Dehner, A., Kessler, H., & Büchner, J. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600611 · Cited by 117
Metadata
- Authors
- Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C.
- Affiliations
- Columbia University (US)
- Medical & Biological Laboratories (Japan) (JP)
- National Cancer Center Research Institute (JP)
- Corresponding author
- Prives, Carol
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1997-10
- Volume
- 91
- Issue
- 3
- Pages
- 325-334
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W1978518304
- Cited by
- 2,100
- References
- 73
- Citations by year
- 2026: 15 · 2025: 25 · 2024: 40 · 2023: 53 · 2022: 72 · 2021: 53 · 2020: 49 · 2019: 45 · 2018: 47 · 2017: 72 · 2016: 50 · 2015: 55 · 2014: 74 · 2013: 86 · 2012: 84
- FWCI
- 45.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cell (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA 58316)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, MDM2, DNA damage response, DNA-dependent protein kinase, p53-MDM2 interaction, protein conformational change
- MeSH terms
- Binding Sites, DNA Damage, DNA-Binding Proteins, Humans, Nuclear Proteins, Phosphorylation, Proto-Oncogene Proteins, Serine, Tumor Cells, Cultured, Transcriptional Activation, Down-Regulation, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Protein Structure, Tertiary, Proto-Oncogene Proteins c-mdm2, DNA-Activated Protein Kinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
